Countries face a range of obstacles to achieving this, including rising prices for new medicines; shortages and stock outs of essential medicines, especially for noncommunicable diseases, and the growing problem of substandard and falsified medical products entering the global supply chain. Added to this, there are other challenges to ensuring that medicines are not only available, but are used appropriately. Antimicrobial resistance has become a worldwide problem largely due to overuse, and misuse of opioids has led to an addiction epidemic in some countries. Knowing where to tackle the problem is the first step. WHO works with Member States to identify what their priorities are on the road to achieving this universal access.
Health products policy and standards
Regulation and Prequalification
Publications
All →The second issue of Volume 38, includesInternational Nonproprietary Names (INN) Proposed List No. 131
The seventy-ninth meeting of the WHO Expert Committee on Biological Standardization was held virtually from 11 to 14 March 2024. The meeting was opened...
This comprehensive document deals with the relevant WTO agreements and the way they may influence health and health policies. In undertaking this joint...
The World Local Production Forum: Enhancing access to medicines and other health technologies (WLPF) brings the global community – foremost government...